Christopher Barry Wood
Gründer bei MedAnnex Ltd.
Profil
Christopher Barry Wood is the founder of Bioenvision, Inc. (1999), Medeva Plc (1986), NuCana Plc (1997), Genethics Ltd.
(1989), MedAnnex Ltd.
(2009), and Thirty Holdings Ltd.
(2018).
He is currently the Chairman of EdixoMed Ltd., Oncobiopharm Ltd., and MiNA Therapeutics Ltd., and a Director at Mina (Holdings) Ltd.
He previously held positions as Chairman & Chief Executive Officer at Eurobiotech, Inc. (1995-1999), Executive Chairman at Navion Ltd., Director at Osteologix, Inc. and Osteologix Holdings Plc, and Senior Medical Adviser at Deepbridge Capital LLP.
Dr. Wood earned a doctorate degree from Cardiff University School of Medicine.
Aktive Positionen von Christopher Barry Wood
| Unternehmen | Position | Beginn |
|---|---|---|
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Vorsitzender | - |
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Gründer | 01.01.2009 |
| Oncobiopharm Ltd. | Vorsitzender | - |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Direktor/Vorstandsmitglied | 17.12.2014 |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Christopher Barry Wood
| Unternehmen | Position | Ende |
|---|---|---|
| NUCANA PLC | Gründer | 25.06.2020 |
Navion Ltd.
 Navion Ltd. Pharmaceuticals: MajorHealth Technology Navion Pharma Ltd. operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases. The company was founded in 2008 and is headquartered in London, GB. | Vorsitzender | 07.01.2014 |
| OSTEOLOGIX HOLDINGS PLC | Direktor/Vorstandsmitglied | 29.12.2009 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Christopher Barry Wood
| Cardiff University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Private Unternehmen | 14 |
|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
| Osteologix, Inc. /Old/ | Health Technology |
| Medeva Plc | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
| Eurobiotech, Inc. | |
Navion Ltd.
Navion Ltd. Pharmaceuticals: MajorHealth Technology Navion Pharma Ltd. operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases. The company was founded in 2008 and is headquartered in London, GB. | Health Technology |
| Genethics Ltd. | |
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Finance |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
| Oncobiopharm Ltd. | |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Technology Services |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Finance |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
